CTLA4 and neoplasm: These tolerogenic DCs present tumor antigen without proper costimulation (CD80/CD86), express inhibitory molecules (PDL1/CTLA4), and secrete immunosuppressive factors (TGF-β, IL-10, IL-27, NO, Arg, and IDO) (54).